PFE
$26.67
Revenue | $17557Mn |
Net Profits | $-1648Mn |
Net Profit Margins | -9.39% |
Pfizer Inc.’s revenue fell -1.16% since last year same period to $17557Mn in the Q4 2025. On a quarterly growth basis, Pfizer Inc. has generated 5.42% jump in its revenue since last 3-months.
Pfizer Inc.’s net profit fell -508.93% since last year same period to $-1648Mn in the Q4 2025. On a quarterly growth basis, Pfizer Inc. has generated -146.54% fall in its net profits since last 3-months.
Pfizer Inc.’s net profit margin fell -513.73% since last year same period to -9.39% in the Q4 2025. On a quarterly growth basis, Pfizer Inc. has generated -144.15% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.73 |
EPS Estimate Current Year | 0.73 |
Pfizer Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.73 - a 28.07% jump from last quarter’s estimates.
Pfizer Inc.’s earning per share (EPS) estimates for the current year stand at 0.73.
Earning Per Share (EPS) | 0.66 |
Dividend Per Share (DPS) | 0.43 |
Pfizer Inc.’s earning per share (EPS) jumped 4.76% since last year same period to 0.66 in the Q4 2025. This indicates that the Pfizer Inc. has generated 4.76% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Pfizer Inc. declared 0.43 dividend per share during the earnings announcement for Q4 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-04 | 0.63 | 0.87 | 38.1% |
2026-02-03 | 0.57 | 0.66 | 15.79% |
2025-05-05 | 0.67 | 0.92 | 37.31% |
2025-08-05 | 0.57 | 0.78 | 36.84% |